Rentokil Initial (RTO) Price Target Cut to GBX 400 by Analysts at Goldman Sachs Group
Rentokil Initial (LON:RTO) had its target price lowered by Goldman Sachs Group from GBX 420 ($5.49) to GBX 400 ($5.23) in a research report sent to investors on Monday morning. The brokerage currently has a neutral rating on the stock.
Other equities research analysts also recently issued reports about the company. Peel Hunt raised Rentokil Initial to an add rating in a research report on Friday, January 25th. JPMorgan Chase & Co. raised their price target on Rentokil Initial from GBX 345 ($4.51) to GBX 350 ($4.57) and gave the company an overweight rating in a research report on Friday, December 14th. Deutsche Bank reaffirmed a hold rating on shares of Rentokil Initial in a research report on Friday, March 1st. Finally, Credit Suisse Group raised their price target on Rentokil Initial from GBX 375 ($4.90) to GBX 400 ($5.23) and gave the company an outperform rating in a research report on Wednesday, December 12th. Six investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of GBX 370.91 ($4.85).
Rentokil Initial stock opened at GBX 345.20 ($4.51) on Monday. The firm has a market cap of $6.33 billion and a price-to-earnings ratio of -65.13. Rentokil Initial has a one year low of GBX 261.90 ($3.42) and a one year high of GBX 361.20 ($4.72). The company has a debt-to-equity ratio of 152.01, a quick ratio of 0.76 and a current ratio of 0.88.
Rentokil Initial Company Profile
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, Europe, Asia, Pacific, and rest of world. It offers a range of pest control services from rodents to flying insects, as well as to other forms of wildlife management for commercial and residential customers.
Further Reading: What Factors Can Affect Return on Equity?
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.